ARCHIVES

NCI blocked groups from phase III Iressa studies.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Jennifer Pietenpol Named to IOM Cancer Policy Board

July 18, 2014

Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.

January 26, 2001

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014

Outside Experts Might Lengthen NDA Approval, Peck Asserts

September 7, 1990

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994

French Cancer Group Vow to Spend More On Cancer Research

January 12, 1996